Harry Rickerby

Harry Rickerby is a prominent figure in the biotechnology sector, currently serving as Co-Founder and CEO of Briefly Bio since September 2022, after co-founding SHK Bio for a brief period in mid-2022. Previously, Rickerby held the position of Platform Architect and Board Director at LabGenius from November 2014 to February 2022, where responsibility encompassed steering the protein engineering platform and managing both scientific and technical teams. Rickerby also contributed as a Principal Scientist at Newcastle University from October 2016 to October 2021 and served on the International Advisory Board for Portabolomics. Rickerby's academic foundation includes a Master of Research in Systems and Synthetic Biology and a Bachelor of Science in Biology, both earned from Imperial College London.